9 Recruiting Studies Using Peposertib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Peposertib
Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma
📍 M D Anderson Cancer Center — Houston, Texas
Glioblastoma
View Study & Checklist ➔Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Locally Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Neuroendocrine Neoplasm
View Study & Checklist ➔A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
📍 UCHealth University of Colorado Hospital — Aurora, Colorado
Endometrial High Grade Endometrioid Adenocarcinoma
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Recurrent Acute Myeloid Leukemia
View Study & Checklist ➔Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Advanced Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Locally Advanced Pancreatic Adenocarcinoma
View Study & Checklist ➔Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
📍 Los Angeles General Medical Center — Los Angeles, California
Metastatic Dedifferentiated Liposarcoma
View Study & Checklist ➔